Cetuximab in combination with capecitabine, irinotecan and concurrent radiotherapy (CAPIRI-RT) for preoperative treatment of locally advanced rectal cancer

被引：0
|
作者：
Hofheinz, RD
Horisberger, K
Tiefenbacher, U
Wenz, F
von Gerstenberg, B
Kähler, G
Post, S
Hochhaus, A
Willeke, F
机构：
[1] Onkol Zentrum, Mannheim, Germany
[2] Med Klin 3, Mannheim, Germany
[3] Chirurg Klin, Mannheim, Germany
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer
    F Willeke
    K Horisberger
    U Kraus-Tiefenbacher
    F Wenz
    A Leitner
    A Hochhaus
    R Grobholz
    A Willer
    G Kähler
    S Post
    R-D Hofheinz
    [J]. British Journal of Cancer, 2007, 96 : 912 - 917
  • [2] A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer
    Willeke, F.
    Horisberger, K.
    Kraus-Tiefenbacher, U.
    Wenz, F.
    Leitner, A.
    Hochhaus, A.
    Grobholz, R.
    Willer, A.
    Kaehler, G.
    Post, S.
    Hofheinz, R-D
    [J]. BRITISH JOURNAL OF CANCER, 2007, 96 (06) : 912 - 917
  • [3] Cetuximab in combination with Capecitabine, irinotecan and simultaneous radiotherapu (CAPIRI-RT) in neoadjuvant treatment in locally advanced rectal cancer - Results of a phase 1 study
    Mai, S. K.
    Thoennessen, D.
    Hofheinz, R.
    von Gerstenbergk-Helldorff, B.
    Horisberger, K.
    Kaehler, G.
    Willeke, F.
    Post, S.
    Hochhaus, A.
    Wenz, F.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 20 - 20
  • [4] Phase II trial of capecitabine and irinotecan in combination with concurrent radiotherapy for neoadjuvant treatment of locally advanced rectal cancer.
    Willeke, F
    Tiefenbacher, U
    Hochhaus, A
    Wenz, F
    von Gerstenbergk, B
    Gnad-Vogt, U
    Horisberger, K
    Post, S
    Hofheinz, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 268S - 268S
  • [5] EXCITE: A PHASE II TRIAL OF PREOPERATIVE CETUXIMAB, IRINOTECAN AND CAPECITABINE PLUS RADIOTHERAPY (RT) IN MRI-DEFINED LOCALLY ADVANCED RECTAL CANCER (LARC)
    Gollins, S.
    Myint, A. S.
    Saunders, M. P.
    Susnerwala, S.
    Sebag-Montefiori, D.
    Beare, S.
    Williams, E.
    West, N.
    Jitlal, M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 206 - 207
  • [6] CETUXIMAB IN COMBINATION WITH CAPECITABINE, IRINOTECAN, AND RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER: RESULTS OF A PHASE II MARGIT TRIAL
    Horisberger, Karoline
    Treschl, Anne
    Mai, Sabine
    Barreto-Miranda, Manuel
    Kienle, Peter
    Stroebel, Philipp
    Erben, Philipp
    Woernle, Christoph
    Dinter, Dietmar
    Kaehler, Georg
    Hochhaus, Andreas
    Post, Stefan
    Willeke, Frank
    Wenz, Frederik
    Hofheinz, Ralf-Dieter
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (05): : 1487 - 1493
  • [7] Preoperative Treatment with Capecitabine, Cetuximab and Radiotherapy for Primary Locally Advanced Rectal Cancer - A Phase II Clinical Trial
    Eisterer, Wolfgang
    De Vries, Alexander
    Oefner, Dietmar
    Rabl, Hans
    Koplmueller, Renate
    Greil, Richard
    Tschmelitsch, Joeerg
    Schmid, Rainer
    Kapp, Karin
    Lukas, Peter
    Sedlmayer, Felix
    Hoefler, Gerald
    Gnant, Michael
    Thaler, Josef
    [J]. ANTICANCER RESEARCH, 2014, 34 (11) : 6767 - 6773
  • [8] Phase I study of radiotherapy (RT) plus concurrent irinotecan (CPT-11) and capecitabine (CAP) as preoperative downstaging treatment for locally advanced inoperable rectal cancer.
    Gollins, SW
    Myint, S
    Levine, E
    Morris, J
    Haylock, B
    Susnerwala, S
    Saunders, M
    Biswas, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 262S - 262S
  • [9] Concurrent radiotherapy with capecitabine and weekly irinotecan as neoadjuvant treatment for locally advanced rectal cancer: a phase I/II study
    Klautke, Gunther
    Feyerherd, Peter
    Ludwig, Kaja
    Foitzik, Thomas
    Klar, Ernst
    Fietkau, Rainer
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 80 - 80
  • [10] Phase I study of irinotecan (CPT-11) and capecitabine in combination with concurrent radiotherapy for locally advanced rectal cancer.
    Hofheinz, R
    Von Gerstenberg, B
    Wenz, F
    Gnad-Vogt, U
    Tiefenbacher, U
    Saussele, S
    Kreil, S
    Hochhaus, A
    Willeke, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 293S - 293S
12345